CBD	Cannabidiol
THC	Δ9-tetrahydrocannabinol
GPCR	G-Protein-Coupled Cannabinoid CB1 Receptor
GlyRα1/α2/β	Glycine Receptor alpha-1, alpha-3, beta
5-HT1A/2A/3A	5-hydroxytryptamine Receptor 1A, 2A, 3A
PPARγ	Peroxisome Proliferator-Activated Receptor Gamma
ARA1	Adenosine A1 Receptor
FDA	U.S. Food and Drug Administration
EMA	European Medicines Agency
CBD-NE	Cannabidiol contained Nanoemulsion
SNEDDS	Self-Nanoemulsifying Drug Delivery System
AUC	Area Under the Curve
Cmax	Maximum Serum Concentration
PNLs	Pro-Nanolipospheres
MLVs	Multilamellar Vesicles
MVVs	Multivesicular Vesicles
GUVs	Giant Unilamellar Vesicles
LUVs	Large Unilamellar Vesicles
SUVs	Small Unilamellar Vesicles
SPC	Soybean Phosphatidylcholine
PEG 400	Polyethylene Glycol 400
PPD	20(S)-Protopanaxadiol
CP-liposomes	Cannabidiol and 20(S)-Protopanaxadiol contained liposomes
GMCP-liposomes	Cannabidiol, 20(S)-Protopanaxadiol and n-Dodecyl β-D-maltoside contained liposomes
PBS	Phosphate-Buffered Saline
HPMCAS	Hydroxypropylmethylcellulose Acetate Succinate
FD	Ester of Fucoidan and Deoxycholic Acid
API	Active Pharmaceutical Ingredient
PLGA	Poly-lactic-co-glycolic acid
NPs	Nanoparticles
CAM	Chorioallantoic Membrane
WP	Whey Protein
β-CD	β-Cyclodextrin
DM-β-CD	2,6-di-O-methyl-β-cyclodextrin